Ozempic and other GLP-1 agonist drugs have become an enormously popular way to lose weight. And with generic, much cheaper versions of the medications on the horizon, their use could soon grow even ...

People taking GLP-1 drugs were more likely to experience certain types of temporary hair loss within a year of starting treatment, a large new study found. Hair shedding is a known side effect of ...

As pharmaceutical companies race to scale synthetic GLP-1s, Evolv is betting that consumers want a natural, orally available version. Evolv co-founder Becca McCarthy saw a massive GLP-1 trend — and ...

Every time Aditi publishes a story, you’ll get an alert straight to your inbox! Enter your email By clicking “Sign up”, you agree to receive emails from ...

With off‑label use surging, it’s virtually impossible to know how many people are currently taking GLP‑1 drugs like Wegovy or Mounjaro, or how many will be prescribed them in the years ahead. The same ...

The growth potential in the GLP-1 market could help healthcare stocks soar in value. Competition, however, is likely to be fierce. Many drugs offer comparable weight loss. Healthcare companies have ...

At just over 5 foot, 5 inches, Christie Woodard weighs a lean 125 pounds. She's also open about relying on a low-dose GLP-1 to keep her weight there. She says sometimes people question why she's on ...

With the use of GLP-1 medications on the rise, cardiologists are seeing benefits to heart health, and it might not all be related to weight loss alone. GLP-1 medications, including semaglutide, are a ...

SYDNEY, Feb 10 (Reuters) - The Australian government has called a meeting with gaming platform Roblox over reports of child grooming and exposure to graphic content on the platform, while a regulator ...

These days, food and drink companies largely fall into two camps: those launching products for the growing wave of GLP‑1 users, and those closely watching the trend from the sidelines. The number of ...

Hims & Hers Health, Inc. is facing increasing regulatory pressure regarding its compounded GLP-1 offering. The GLP-1 revenue stream has been significant for HIMS, but not the only source of growth.

McDonald’s signaled this week it’s looking to better cater to customers on weight-loss drugs — and the name of the game is protein. During a Wednesday earnings call, McDonald’s CEO Chris Kempczinski ...